By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Acceleron Pharma 

128 Sidney Street

Cambridge  Massachusetts    U.S.A.
Phone: 617-649-9200 Fax: 617-649-9988


SEARCH JOBS


Industry
Pharmaceutical


Collaborations

Alkermes 





Company News
Acceleron Pharma Announces Plans To Initiate A Phase II Trial Of ACE-083 In Charcot-Marie-Tooth Neuromuscular Disease And Host Educational Webinar 3/16/2017 6:20:37 AM
Acceleron Pharma Reports Fourth Quarter And Year Ended 2016 Operational And Financial Results 3/1/2017 6:25:31 AM
Acceleron Pharma To Webcast Conference Call Of Fourth Quarter And Year Ended 2016 Financial Results On March 1, 2017 2/22/2017 6:39:06 AM
Acceleron Pharma Outlines Corporate Goals And Priorities For 2017 1/6/2017 11:13:22 AM
Acceleron Pharma Announces First Patient Treated In Phase 2 Trial Of ACE-083 In Facioscapulohumeral Muscular Dystrophy 12/27/2016 11:21:50 AM
Acceleron Pharma And Celgene (CELG) Announce Updated Results From Phase 2 Studies Of Luspatercept In Beta-Thalassemia Presented At The 58th Annual Meeting Of American Society of Hematology 12/6/2016 11:14:54 AM
Acceleron Pharma And Celgene (CELG) Announce Updated Results From Ongoing Phase 2 Studies Of Luspatercept In Myelodysplastic Syndromes At The 58th Annual Meeting Of American Society of Hematology 12/5/2016 1:22:08 PM
Acceleron Pharma And Celgene (CELG) Announce Preliminary Results From An Investigator Initiated Phase 2 Study Of Sotatercept In Myelofibrosis At The 58th Annual Meeting Of American Society of Hematology 12/5/2016 12:50:14 PM
Acceleron Pharma Reports Third Quarter 2016 Financial And Operational Results 11/4/2016 10:56:10 AM
Acceleron Pharma To Webcast Conference Call Of Third Quarter 2016 Financial Results On November 3, 2016 10/27/2016 11:35:18 AM
12345678910...
//-->